Cargando…
Identification of Cancer-Associated Circulating Cells in Anal Cancer Patients
Whilst anal cancer accounts for less than 1% of all new cancer cases, incidence rates have increased by up to 70% in the last 30 years with the majority of cases driven by human papilloma virus (HPV) infection. Standard treatment for localised anal cancer is chemoradiotherapy (CRT). Localised progre...
Autores principales: | Carter, Thomas J., Jeyaneethi, Jeyarooban, Kumar, Juhi, Karteris, Emmanouil, Glynne-Jones, Rob, Hall, Marcia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7465059/ https://www.ncbi.nlm.nih.gov/pubmed/32785154 http://dx.doi.org/10.3390/cancers12082229 |
Ejemplares similares
-
Identification of Potential Bisphenol A (BPA) Exposure Biomarkers in Ovarian Cancer
por: Zahra, Aeman, et al.
Publicado: (2021) -
Surfactant Protein D as a Potential Biomarker and Therapeutic Target in Ovarian Cancer
por: Kumar, Juhi, et al.
Publicado: (2019) -
A pancancer overview of FBN1, asprosin and its cognate receptor OR4M1 with detailed expression profiling in ovarian cancer
por: Kerslake, Rachel, et al.
Publicado: (2021) -
Differential Regulation of Genes by the Glucogenic Hormone Asprosin in Ovarian Cancer
por: Kerslake, Rachel, et al.
Publicado: (2022) -
Identification of cancer biomarkers of prognostic value using specific gene regulatory networks (GRN): a novel role of RAD51AP1 for ovarian and lung cancers
por: Chudasama, Dimple, et al.
Publicado: (2018)